Publications by authors named "Julio Nieves"

Claim this Profile
N
Nonclinical study of ixo-vec gene therapy for nAMD supports efficacy for a human dose of 6E10 vg/eye and staggered dosing of fellow eyes.
Kris Poulsen, Kelly Hanna, Julio Nieves, Ngoc Nguyen, Pallavi Sharma

Mol Ther Methods Clin Dev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacy.
Kelly Hanna, Julio Nieves, Christine Dowd, Kristina Oresic Bender, Pallavi Sharma

Mol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.
Claire M Gelfman, Ruslan Grishanin, Kristina Oresic Bender, Aivan Nguyen, Judith Greengard, Julio Nieves

J Ocul Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates.
Szilárd Kiss, Kristina Oresic Bender, Ruslan N Grishanin, Kelly M Hanna, Julio D Nieves

Transl Vis Sci Technol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.
Szilárd Kiss, Ruslan Grishanin, Aivan Nguyen, Romeo Rosario, Judith S Greengard, Julio Nieves

Mol Ther Methods Clin Dev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis